Teicoplanin and vancomycin as treatment for glycopeptide-susceptible Enterococcus faecium bacteraemia: a propensity score-adjusted non-inferior comparative study

• Published in: Journal of antimicrobial chemotherapy Vol. 78; no. 5; pp. 1231 - 1240
• Main Authors: Yamaguchi, Ryo, Yamamoto, Takehito, Okamoto, Koh, Harada, Sohei, Echizenya, Miho, Tsutsumi, Takeya, Takada, Tappei
• Format: Journal Article
• Language: English
• Published: US Oxford University Press 03.05.2023
• Subjects: Acute Kidney Injury - drug therapy; Adolescent; Adult; Anti-Bacterial Agents - adverse effects; Bacteremia - drug therapy; Cohort Studies; Enterococcus faecium; Glycopeptides - adverse effects; Humans; Original Research; Propensity Score; Retrospective Studies; Teicoplanin - adverse effects; Vancomycin - adverse effects

Abstract Objectives Limited evidence is available regarding alternative therapeutic agents to vancomycin in treating glycopeptide-susceptible Enterococcus faecium (GSEF) bacteraemia. This study assessed the effectiveness and safety of teicoplanin compared with vancomycin for treating GSEF bacteraemi...